Evercyte showcasing extracellular vesicle capabilities at GSEV/ASEV Autumn Meeting 2022

Evercyte GmbH News Releases

Find the latest News from Evercyte GmbH

Page 2 of 5
Evercyte showcasing extracellular vesicle capabilities at GSEV/ASEV Autumn Meeting 2022
Evercyte showcasing extracellular vesicle capabilities at GSEV/ASEV Autumn Meeting 2022 Learn More >
Evercyte to present EV cell factory advances to Bioproduction Congress, Lyon
Evercyte to present EV cell factory advances to Bioproduction Congress, Lyon Learn More >
Evercyte helps pioneer standardized production of spheroids for tissue engineering
Evercyte helps pioneer standardized production of spheroids for tissue engineering Learn More >
Evercyte showcasing latest extracellular vesicle ‘cell factories’ and revolutionary CD81 targeting at ISEV 2022 Lyon
Evercyte showcasing latest extracellular vesicle ‘cell factories’ and revolutionary CD81 targeting at ISEV 2022 Lyon Learn More >
Evercyte bringing EV partnership opportunities to BIO-Europe Spring online summit
Evercyte bringing EV partnership opportunities to BIO-Europe Spring online summit Learn More >
Evercyte adds placenta/amnion derived MSCs to its ‘cell factory’ lines
Evercyte adds placenta/amnion derived MSCs to its ‘cell factory’ lines Learn More >
Evercyte joins EU LIFESAVER project to study ‘hidden’ maternal and fetal health influences
Evercyte joins EU LIFESAVER project to study ‘hidden’ maternal and fetal health influences Learn More >
New study confirms effectiveness of unique Evercyte CD81 antigen recognition technology
New study confirms effectiveness of unique Evercyte CD81 antigen recognition technology Learn More >
MDimune and Evercyte form partnership for developing tumor-targeting EVs
MDimune and Evercyte form partnership for developing tumor-targeting EVs Learn More >
Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting
Evercyte bringing EV toolbox insights to GSEV/ASEV Autumn Meeting Learn More >
Evercyte bringing latest cell-based advances to BIO-Europe Hamburg
Evercyte bringing latest cell-based advances to BIO-Europe Hamburg Learn More >
Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama
Evercyte promotes human telomerized cells for preclinical testings and oduction of exosomes at BioJapan in Yokohama Learn More >
Page 2 of 5